Researchers have identified a link between reduced arginine levels and major depressive disorder.
Researchers report the hypothalamus is, on average, five percent larger in those with mood disorders like major depressive disorder and bipolar disorder, than it is in those without depression.
The amygdala-pons connectivity in the pons-corticolimbic network is significantly stronger in patients with major depressive disorder.
Neurofeedback training can alter guilt-related networks and improve self-esteem in those with major depressive disorder.
Researchers report intermittent theta burst stimulation can help to alleviate the symptoms of major depressive disorder. 49% of patients who received the treatment reported a significant decrease in symptoms, with 32% reporting remission of depression.
Exposing depressed adolescents to positive and negative words elicited different effects in specific brain regions depending on the sex of the subject, a new Frontiers in Psychiatry study reports.
Researchers discover common white matter abnormalities in multiple emotional disorders.
For those with treatment resistant depression, a new study reports ECT may not only be the most effective treatment, but also the most cost effective.
Antidepressants for major depressive disorder reduce the aversive response triggered by exposure to the suffering of others. Findings suggest antidepressants may lead to impaired empathy of pain perception.
White matter integrity appears to be reduced in people with major depressive disorders, a new Scientific Reports study reveals.
According to a new study, postmortem brain tissue from females who suffered from depression had abnormally high expression levels of a number of genes which regulate the glutamate system.
A new study reports patients with major depressive disorder and treatment resistant depression have decreased levels of acetyl-L-carnitine in their blood. The findings could lead to new blood tests to diagnose the nature and severity of depression.
